Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
Wednesday, December 08, 2021Telix Pharmaceuticals Limited announces that it has entered into an exclusive commercial distribution agreement with Madridbased NUCLIBER SA Spain NUCLIBER for Telixs prostate cancer investigational imaging product Illuccix Kit for the preparation of...
Recursion and Bayer Expand Fibrosis Collaboration to Include Inferential Search Capabilities
Tuesday, December 07, 2021Recursion a clinicalstage biotechnology company decoding biology to radically improve lives by industrializing drug discovery development and beyond through disruptive innovation today announced expansion of the companys existing strategic collaborat...
Gritstone bio and CEPI Expand Vaccine Agreement to Tackle Omicron Variant
Tuesday, December 07, 2021Gritstone bio Inc a clinicalstage biotechnology company developing next generation cancer and infectious disease immunotherapies and CEPI the Coalition for Epidemic Preparedness Innovations today announced the expansion of their agreement in order to...
Jacobio Receives IND Approval for Combination Therapy of KRAS G12C and Cetuximab Injection in China
Monday, December 06, 2021Jacobio Pharma HK has received the Investigational New Drug the IND approval of the combination therapy of KRAS GC inhibitor JAB and Cetuximab injection from the Center for Drug Evaluation of China the CDE on Dec After received the approval Jacobi...
Resilience Acquires SwiftScale Biologics, a Leader in Cell-Free Protein Synthesis Technology
Friday, December 03, 2021National Resilience Inc Resilience a technology focused manufacturing company dedicated to broadening access to complex medicines today announced the acquisition of SwiftScale Biologics a San Leandro Californiabased company developing cellfree protei...
NJ Bio Expands Its State-Of-The-Art Facility in Princeton, New Jersey
Friday, December 03, 2021NJ Biopharmaceuticals LLC an expert provider of chemistry and biopharmaceutical services specializing in bioconjugation custom synthesis flow chemistry and process development has expanded its footprint at its stateoftheart laboratory and headquarter...
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
Thursday, December 02, 2021Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH an Austrian privately owned biotechnology company specializing in the discovery of virulent skin microbiome components and antigens from bacteria causing skin d...
Astellas and Dyno Therapeutics Announce Research Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Skeletal and Cardiac Muscle
Thursday, December 02, 2021Astellas Pharma Inc and Dyno Therapeutics Inc announced an option and license agreement was signed on November to develop nextgeneration adenoassociated virus AAV vectors for gene therapy directed to skeletal and cardiac muscle using Dynos CapsidMap...
UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases
Wednesday, December 01, 2021UCB a global biopharmaceutical company and Chiesi Group the international researchfocused pharmaceutical and healthcare group are pleased to announce that they have entered into an agreement that grants Chiesi a worldwide exclusive license to develop...
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application (IND) for IRAKIMiD Degrader, KT-413
Wednesday, December 01, 2021Kymera Therapeutics Inc a clinicalstage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines today announced the clearance of its Investigational New Drug IND application from the...
